Name: Deborah Dunsire
Current Company: Millennium, the Takeda Oncology Company
Title: President and CEO
Profile: Deborah Dunsire's life has been a long and successful journey to the top of the biotech industry. The Africa-born daughter of Scottish parents grew up to become a doctor and eventually chief of Novartis' North American oncology business, where she turned her passion for healing into a career centered on a string of major cancer drug launches. And when Millennium went looking for a new CEO, it found just what it was looking for in Dunsire, who quickly revived flagging sales of Velcade as she started to remake the company's pipeline.
Dunsire's success at Millennium proved a boon to investors, who picked up a big premium when Takeda bought out the company for $8.8 billion. And she's stayed on, still pushing to be the best there is in the world of oncology; still striving to do well in business by doing well for cancer patients. Dunsire likes to say that excellence is a habit. Routine success has become her habitual reward.
1. What do you think has contributed to your success in this industry?
The most important factor for me has been working with great people and learning from all of them! My medical training is a big help but there is no real course that trains you in biotech drug discovery and development--it's an apprenticeship, so learn from everyone! I've also benefited from being willing to step outside my comfort zone and risk failing by trying new things--moving out of clinical into commercial roles, moving internationally, and taking on feedback. I love learning and growing and this industry demands a lot of that! I feel I have also been blessed to work on great medicines that turned out to bring radical improvement to patients. Not everybody gets that experience, no matter how good they are.
2. What advice would you give to women just starting out in biotech?
Be passionate about your work and the fact that through the biotech work we do we can change outcomes in human health. Always focus on how you can advance progress to that goal through your work, and look for ways to innovate to make your company faster and more effective. Get broad exposure to as many of the major strategic areas for a biotech as possible, including discovery, development, commercialization and financing. Never lose sight of the fact that real progress is made through deep understanding of emerging science. No matter what your role in a biotech, you must be deeply interested in the quality and focus of the science in the enterprise. Be optimistic but grounded--there will be many disappointments, but learn from failure and rise up and do it better.